In Africa: Jumia and Reckitt Benckiser Partner to Provide Consumers Access to Hygiene Products

The partnership will provide a steady supply of hygiene products such as soap bars, disinfectants, and liquid hand wash at affordable pricing. These products are facing growing demand from consumers taking hygiene precautions to prevent the spread of the COVID-19. Jumia will be taking 0% commission on Dettol, JIK and Harpic, and will reinvest the initial commission into discounts on the consumer price.

Reckitt Benckiser is financing free shipping nationwide on all listed products. Consumers will be able to access all products from the “Stay Safe” page on Jumia, co-owned with Reckitt Benckiser.

“At Jumia, our primary concern is the health and well-being of our teammates, consumers, partners, and communities. We strive to continue operating so that customers continue to use eCommerce as a safe way to shop in this challenging time. We are proud to work closely with Reckitt Benckiser through the “Stay Safe” campaign, which shares consistent information about COVID-19 and provides access to key hygiene products at the most affordable price possible for our consumers,” said Romain Christodoulou, SVP Jumia Group.

The partnership will also provide critical information around COVID-19. Reckitt Benckiser has created the Mythbuster website to help update consumers on risks and best practices to avoid the virus from spreading. Jumia is creating several awareness campaigns which direct consumers to both the ‘Stay Safe’ page and the ‘Mythbuster’ website.

“Reckitt Benckiser is delighted to partner with Jumia to ensure that access to the highest quality hygiene and health products is a right, not a privilege. By financing nationwide free shipping in all markets where Jumia operates, from capital cities to more rural areas, Reckitt Benckiser is providing fair access to supply for all consumers, regardless of their location,” said Bart Meermans, SVP RB Health Africa/ Middle East / Turkey.

“The Federal Competition & Consumer Protection Commission welcomes the proactive, innovative and socially responsible approach Jumia and Reckitt Benckiser have adopted in addressing potential supply shortages in key hygiene products, ensuring affordability and accessibility, and promoting awareness regarding COVID-19. FCCPC appreciates this and encourages similar dynamism that is consumer-focused and provides value to consumers and society at large. We look forward to successful outcomes from this collaboration and will provide required regulatory support that the intention for affordable access is not frustrated or exploited by any and that those who demonstrate corporate social responsibility are not at a competitive disadvantage against those who do otherwise” said Mr Babatunde Irukera, the Director-General of the Federal Competition & Consumer Protection Commission of Nigeria (FCCPC).

The partnership will cover 8 of the markets where Jumia operates, Algeria, Egypt, Ghana, Kenya, Morocco, Nigeria, South Africa, and Uganda.

SourceJumia

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”